These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
667 related articles for article (PubMed ID: 2215576)
1. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. Chapman AB; Johnson A; Gabow PA; Schrier RW N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576 [TBL] [Abstract][Full Text] [Related]
2. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. van Hooft IM; Grobbee DE; Derkx FH; de Leeuw PW; Schalekamp MA; Hofman A N Engl J Med; 1991 May; 324(19):1305-11. PubMed ID: 2017226 [TBL] [Abstract][Full Text] [Related]
3. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
4. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease. Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161 [TBL] [Abstract][Full Text] [Related]
5. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension]. Marzecka J Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117 [TBL] [Abstract][Full Text] [Related]
6. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion. Barendregt JN; Florijn KW; Muizert Y; Chang PC Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923 [TBL] [Abstract][Full Text] [Related]
7. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494 [TBL] [Abstract][Full Text] [Related]
8. [The long-term effects of a new converting enzyme inhibitor, delapril hydrochloride, on renal function, renin-angiotensin-aldosterone system and kallikrein-kinin prostaglandin system in hypertensive patients]. Nishiyama K; Igari T; Nanba S; Ishii M Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):801-7. PubMed ID: 2273596 [TBL] [Abstract][Full Text] [Related]
9. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483 [TBL] [Abstract][Full Text] [Related]
10. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. Schrier RW J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226 [TBL] [Abstract][Full Text] [Related]
11. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326 [TBL] [Abstract][Full Text] [Related]
12. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
13. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension. Hannila-Handelberg T; Kontula K; Tikkanen I; Tikkanen T; Fyhrquist F; Helin K; Fodstad H; Piippo K; Miettinen HE; Virtamo J; Krusius T; Sarna S; Gautschi I; Schild L; Hiltunen TP BMC Med Genet; 2005 Jan; 6():4. PubMed ID: 15661075 [TBL] [Abstract][Full Text] [Related]
14. Hypertension in polycystic kidney disease without renal failure. Nash DA Arch Intern Med; 1977 Nov; 137(11):1571-5. PubMed ID: 921444 [TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease. Steele JL; Henik RA; Stepien RL Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747 [TBL] [Abstract][Full Text] [Related]
16. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890 [TBL] [Abstract][Full Text] [Related]
17. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis. Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031 [TBL] [Abstract][Full Text] [Related]
18. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Ecder T; Schrier RW Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483 [TBL] [Abstract][Full Text] [Related]
19. [Hypertension in patients with polycystic kidneys--the effect of volume expansion]. Zabka J; Tesar V; Merta M; Horký K; Petrtýl J; Jedlicka J; Stolba P; Gregorová I; Marecek Z Sb Lek; 1991 Oct; 93(9-10):325-38. PubMed ID: 1821466 [TBL] [Abstract][Full Text] [Related]
20. Renal function and hemodynamic studies in low- and normal-renin essential hypertension. Bauer JH; Brooks CS; Burch RN Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]